| Patents for C07J 33 - Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (413) |
|---|
| 10/28/2003 | CA2077625C Preparation process of hydrocortisone and novel intermediates |
| 10/23/2003 | US20030199485 Novel anti-inflammatory androstane derivative |
| 08/27/2003 | CN1439018A 9alpha-chloro-6alpha-fluoro-17alpha-hydroxy-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl group |
| 08/26/2003 | US6610675 Inactive metabolite approach to soft drug design |
| 08/21/2003 | US20030158163 Conversion of carboxylic acid substituent in a gonane ring, into the methyl ester, or hydrochlorination of a 9-11-epoxy-9-H-cyclopenta(a)phenanthrene compounds |
| 07/31/2003 | WO2003035668A3 Novel anti-inflammatory androstane derivatives -17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 06/03/2003 | CA2332652C .delta.16 unsaturated c17 heterocyclic steroids useful as steroid c17-20 lyase inhibitors |
| 05/22/2003 | WO2003042230A1 Non-aromatic heterocyclic esters of furan-2-one-esters of 17. beta.-carboxyl or 17 . beta. -carbothio glucocorticoids |
| 05/22/2003 | WO2003042229A1 Non-aromatic heterocyclic esters of furan-2-one-esters of 17.beta.-carboxyl or 17.beta.-carbothio glucocorticoids |
| 05/21/2003 | EP1311302A2 Pharmaceuticals for the imaging of angiogenic disorders |
| 05/15/2003 | US20030092690 Administering by inhalation |
| 05/02/2003 | EP1305330A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents |
| 05/02/2003 | EP1305329A1 6.alpha.,9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl)oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 05/01/2003 | WO2003035668A2 Novel anti-inflammatory androstane derivatives -17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 04/09/2003 | EP1299409A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 03/25/2003 | US6537983 Anti-inflammatory androstane derivatives |
| 03/06/2003 | US20030045512 Androstanecarbothioic acid derivatives, especially esterified with thazol-5-ylcarboxylic acid; formulation for administration by inhalation |
| 03/05/2003 | EP1140972B1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 02/27/2003 | WO2001097860A3 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/19/2002 | WO2002100879A1 Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives |
| 12/10/2002 | CA2084313C Process for the production of 10beta-h-steroids |
| 11/21/2002 | WO2002092631A1 Kinetic assay |
| 11/21/2002 | CA2447032A1 Kinetic assay |
| 08/01/2002 | US20020103392 Corticoid-17,21-dicarboxylic esters and corticosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 07/24/2002 | CN1360591A 3 alpha-hydroxy-3 beta-methoxymethyl-21-heterocycle substd. steroids with anesthetic activity |
| 04/24/2002 | CN1346364A 16-hydroxyestratrienes as selective estrogens |
| 04/17/2002 | EP1196428A1 11$g(b)-ARYL-17,17-SPIROTHIOLANE-SUBSTITUTED STEROIDS |
| 03/28/2002 | WO2002000679A3 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 03/28/2002 | WO2001066560A3 Novel derivatives comprising phytosterols and/or phytostanols and alpha-lipoic and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders |
| 02/14/2002 | WO2002012266A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/14/2002 | WO2002012265A1 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT |
| 02/14/2002 | US20020019378 Compounds |
| 02/14/2002 | CA2634715A1 6.alpha.,9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl)oxy}-11.beta.-hydroxy-16.alpha-methyl-3-oxo-androsta-1,4-diene-17.beta.carbothioic acids-fluoromethyl ester as an anti-inflammatory agent |
| 02/14/2002 | CA2417826A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/06/2002 | EP1177206A1 3alpha-hydroxy-3beta methoxymethyl-21-heterocycle substituted steroids with anaesthetic activity |
| 01/03/2002 | WO2002000679A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 12/27/2001 | WO2001097860A2 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/27/2001 | CA2413328A1 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 10/17/2001 | EP1144431A2 16-hydroxyestratrienes as selective estrogens |
| 10/10/2001 | EP1140972A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 09/13/2001 | WO2001066560A2 Novel derivatives comprising phytosterols and/or phytostanols and alpha-lipoic and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders |
| 09/07/2001 | WO2000047603A9 16-hydroxyestratrienes as selective estrogens |
| 08/21/2001 | US6277838 Methods for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| 08/02/2001 | WO2000047603A3 16-hydroxyestratrienes as selective estrogens |
| 08/02/2001 | EP1144431A3 16-hydroxyestratrienes as selective estrogens |
| 07/10/2001 | US6258803 11-ethyl-17-hydroxy-19-norpregn-4-en-20-yn-3-one for menopause treatment |
| 06/06/2001 | CN1298409A 20-keto-11&beta, -arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/15/2001 | CA2173729C .delta.16 unsaturated c17 heterocyclic steroids useful as steroid c17-20 lyase inhibitors |
| 03/15/2001 | WO2000066614A8 3α-HYDROXY-3β METHOXYMETHYL-21-HETEROCYCLE SUBSTITUTED STEROIDS WITH ANESTHETIC ACTIVITY |
| 02/28/2001 | CN1062562C Corticosteroid 17-alkyl carbonate 21-[0]-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds |
| 02/01/2001 | WO2001007462A1 11β-ARYL-17,17-SPIROTHIOLANE-SUBSTITUTED STEROIDS |
| 12/20/2000 | EP1060186A1 20-keto-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 11/09/2000 | WO2000066614A1 3α-HYDROXY-3β METHOXYMETHYL-21-HETEROCYCLE SUBSTITUTED STEROIDS WITH ANESTHETIC ACTIVITY |
| 11/09/2000 | CA2372342A1 3.alpha.-hydroxy-3.beta. methoxymethyl-21-heterocycle substituted steroids with anesthetic activity |
| 11/07/2000 | US6143736 Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| 09/27/2000 | EP1038880A2 Androstanes and pregnanes for allosteric modulation of GABA receptor |
| 09/06/2000 | CN1056151C 17-deoxycorticosteroid-21-(O)-carboxylic esters, process for their preparation and pharmaceuticals containing these compounds |
| 08/23/2000 | EP0752860B1 Androstanes and pregnanes for allosteric modulation of gaba receptor |
| 08/17/2000 | WO2000047603A2 16-hydroxyestratrienes as selective estrogens |
| 08/17/2000 | CA2359660A1 16-hydroxyestratrienes as selective estrogens |
| 08/10/2000 | DE19906159A1 16-Hydroxyestratriene als selektiv wirksame Estrogene 16-hydroxyestratrienes as selective estrogens effective |
| 07/06/2000 | WO2000039148A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 07/05/2000 | EP0554436B1 Gaba receptor modulators |
| 06/29/2000 | DE19860719A1 Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen New testosterone derivatives and their use for long-term therapy of androgen-dependent diseases |
| 05/10/2000 | EP0998484A1 Tharapeutically active compounds with low systemic activity due to reduced half-life |
| 04/25/2000 | CA2001936C Methods and compositions for controlling ocular hypertension with angiostatic steroids |
| 04/12/2000 | CN1051316C Cortinoid derivative, its producing process and medicine containing the same |
| 03/28/2000 | US6043235 11β-aryl-17, 17-spirothiolane-substituted steroids |
| 03/14/2000 | US6037339 C-11 substituted steroids for treating menopausal complaints |
| 02/01/2000 | US6020328 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 01/18/2000 | US6015806 Topical use in the treatment of androgen-dependent diseases associated with the skin. |
| 01/04/2000 | US6011025 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 11/24/1999 | CN1046736C 'Delta' 16 unsaturated and (1) heterocyclic steroids useful s steroid (1)-20 lyase inhibitors |
| 11/24/1999 | CN1046735C Steroids for treating menopausal complaints |
| 11/02/1999 | US5977094 Methods and compositions using Δ16 unsaturated C17 heterocyclic steroids useful as steroid C17-20 lyase inhibitors |
| 10/12/1999 | US5965548 For treatment of prostatic cancer, breast cancer |
| 09/10/1999 | WO1999045022A1 20-KETO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES |
| 08/17/1999 | US5939545 Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 05/19/1999 | CN1043426C Pregna-4,9(11), 16-triene-3,20-dione derivs. prepn. method |
| 05/14/1999 | WO1999001467A3 Therapeutically active compounds with low systemic activity due to reduce half life |
| 03/17/1999 | EP0724591B1 Delta 16 unsaturated c 17 heterocyclic steroids useful as steroid c 17-20 lyase inhibitors |
| 01/14/1999 | WO1999001467A2 Therapeutically active compounds with low systemic activity due to reduce half life |
| 10/20/1998 | US5824670 17-deoxycorticosteroid-21- O!carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 09/02/1998 | CN1039646C Preparation process for an 11-keto steroid derivatives |
| 06/23/1998 | CA1339924C 11beta-phenyl-14betha steroids |
| 06/02/1998 | US5760256 Reduction; epoxidation; hydrolysis; acylation |
| 05/26/1998 | US5756722 Intermediates for the preparation of Δ4,9(11),17(20) -pregnatriene-3-ones |
| 02/24/1998 | US5721227 17-aryl and 17-heterocyclyl-14β-5α-androstane, androstene and androstadiene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
| 01/20/1998 | US5710144 Osteoporosis |
| 11/05/1997 | CN1036342C Process for preparing 9,11-dehydro steroids and 9-alpha-hydroxy-16,17-dehydro steroids |
| 10/14/1997 | US5677293 16 unsaturated C17 heterocyclic steroids useful as steroid C17-20 lyase inhibitors |
| 09/24/1997 | CN1035947C Preparation process for hydrocortisone and intermediates |
| 08/27/1997 | EP0567469B1 14beta-H-, 14- AND 15-EN-11beta-ARYL-4-ESTRENES |
| 06/18/1997 | CN1035182C Prep. of 9-alpha-hydroxy steroids compound |
| 05/14/1997 | CN1034867C Preparing method for derivatives of progester-4,9(11), 17(20)-triene-3-one |
| 04/16/1997 | CN1147520A 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/08/1997 | US5618806 Steroid 5alpha-reductase inhibitor; useful for treating benign prostatic hypertrophy, baldness, acne, vulguris, seborrhea, female hirsutism, and prostatic adenocarcinoma |
| 03/19/1997 | EP0763541A1 11-(Substituted phenyl)-estra-4,9-diene derivatives |
| 03/04/1997 | US5608093 Corticosteroid 17-alkyl carbonate 21-[0]-carboxylic and carbonic esters, and pharmaceuticals containing these compounds |
| 01/15/1997 | EP0752860A1 Androstanes and pregnanes for allosteric modulation of gaba receptor |